Andreas Hilgeroth
Hat mitgewirkt an:
-
Novel Symmetrical Cage Compounds as Inhibitors of the Symmetrical MRP4-Efflux Pump for Anticancer Therapy
-
Dimere 4-Aryl-1,4-Dihydropyridine als neuartige Leitstrukturen für die Entwicklung von HIV-1-Proteaseinhibitoren
-
Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. Molecules 2021, 26, 18
-
Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy